Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Power Mall warning letter

This article was originally published in The Tan Sheet

Executive Summary

FDA cites claims that Power Mall's Q Gel dietary supplement can "provide effective treatment of heart disease, chronic fatigue and support during cancer treatment" in a recent warning letter to the company. A review of the firm's website also finds that Gastro Enzymes claims to treat "ulcers, colitis, duodenal ulcer, gastritis, unexplained blood in urine..." the agency adds. Other products cited in the letter for making drug claims include Taurine Spray, AsmaSpray,D-Lenolate,Curcumin98,OxySorb, Eskimo 3 Fish Oil and AtaXanthin. FDA allows Power Mall 15 working days to notify the agency of the steps it is taking to correct the violations...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel